Arkansas Statutes

§ 20-77-138 — Medications approved by United States Food and Drug Administration for tobacco cessation coverage

Arkansas·Title 20
(a)The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation:
(1)Nicotine replacement therapy patches;
(2)Nicotine replacement therapy gum;
(3)Nicotine replacement therapy lozenges;
(4)Nicotine replacement therapy nasal spray;
(5)Nicotine replacement therapy inhalers;
(6)Bupropion; and (7) Varenicline.
(b)Prior authorization shall not be required for coverage of medications described in subsection (a) of this section.

Free access — add to your briefcase to read the full text and ask questions with AI

Arkansas § 20-77-138 (Medications approved by United States Food and Drug Administration for tobacco cessation coverage) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

Added by Act 2019, No. 959,§ 2, eff. 7/24/2019.

Nearby Sections

15
View on official source ↗